Skip to main content
. Author manuscript; available in PMC: 2023 Apr 15.
Published in final edited form as: Cytometry B Clin Cytom. 2022 Jan 10;102(2):88–106. doi: 10.1002/cyto.b.22053

Table 3:

Analysis of participant survey following Stage 1 to determination sample adequacy


Option
Sufficiency of bone marrow cell populations in defining an adequate sample as considered by each participant, n (%)

Very Sufficient Somewhat sufficient Somewhat insufficient Not sufficient at all No Response

Unweighted
 Abnormal PCs only 3 (18) 4 (24) 2 (12) 5 (29) 3 (18)
 Mast cells only 1 (6) 9 (53) 4 (24) 0 (0) 3 (18)
 Hematogones only 2 (12) 5 (29) 6 (35) 1 (6) 3 (18)
 Erythroid Precursors only 0 (0) 6 (35) 3 (18) 5 (29) 3 (18)
 Myeloid Precursors only 0 (0) 6 (35) 5 (29) 2 (12) 4 (24)
2 or more cell populationsa 13 (76) 4 (24) 0 (0) 0 (0) 0 (0)
 All cell populations 10 (59) 0 (0) 0 (0) 1 (6) 6 (35)

Weightedb Scores

   4 3 2 1 Weighted Total

 Abnormal PCs only 12 12 4 5 33
 Mast cells only 4 27 8 0 39
 Hematogones only 8 15 12 1 36
 Erythroid Precursors only 0 18 6 5 29
 Myeloid Precursors only 0 18 10 2 30
2 or more cell populationsa 52 12 0 0 64
 All cell populations 40 0 0 1 41
a

Provided one of the cell populations is mast cells

b

Each response was given a weight and the results retabulated: very sufficient: 4; somewhat sufficient: 3; somewhat not sufficient: 2; not sufficient at all: 1; no response: 0 (omitted from table)

Bold type: Consensus criteria adopted for sample adequacy